2.44
0.41%
-0.01
시간 외 거래:
2.44
Moleculin Biotech Inc (MBRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
25.14%
6.677
|
8.919 | 5.947 | 6.411 | 8.354 |
Operating Income/Loss |
25.14%
-6.677
|
-8.919 | -5.947 | -6.411 | -8.354 |
Income/Loss From Continuing Operations Before Tax |
51.60%
-4.97
|
-10.27 | -5.609 | -5.976 | -7.915 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
51.60%
-4.97
|
-10.27 | -5.609 | -5.976 | -7.915 |
Net Income/Loss
|
51.60%
-4.97
|
-10.27 | -5.609 | -5.976 | -7.915 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
108.99%
2.4662
|
-27.44 | 29.81 | 29.69 | 28.75 |
Basic Earnings Per Share |
85.98%
-2.02
|
-14.41 | -0.19 | -0.20 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):